A Phase Ⅰ/Ⅱa Study of SNUG01 in Adult Subjects With ALS

Clinical trial NCT07169175 · NOT_YET_RECRUITING

Trial details

NCT number: NCT07169175
Sponsor: SineuGene Therapeutics Co., Ltd.
Status: NOT_YET_RECRUITING
Phase: Phase 1, Phase 2
Study type: INTERVENTIONAL

Amyotrophic Lateral Sclerosis (ALS)

Start date: 2025-12-01
Primary completion: 2028-03-30
Enrollment: 21

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.